Navigation Links
Sinobiopharma Reports Highlights From Audited Financial Results for the Fiscal Year Ended May 31, 2009
Date:9/23/2009

NANTONG CITY, China, Sept. 23 /PRNewswire-Asia-FirstCall/ -- Sinobiopharma, Inc. ("Sinobiopharma" or the "Company") is pleased to report financial highlights from the audited financial results for the fiscal year ended May 31, 2009.

    Financial highlights include:
    -- Sales revenue increased to US$3,850,278 for the 12 months ended May 31,
       2009, from US$1,810,318 in the corresponding period ended May 31, 2008,
       a year-over-year increase of 112.69 percent.

    -- Gross profit increased to US$2,538,441, representing 66 percent of
       sales revenue, for the 12 months ended May 31, 2009, from US$580,915,
       representing 32 percent of revenue, in the corresponding period ended
       May 31, 2008.

    -- Net profit of the Company's wholly owned operating subsidiary, Dong
       Ying (Jiangsu) Pharmaceutical Co., Ltd., increased to US$1,019,507
       representing 26% of sales revenue, for the 12 months ended May 31, 2009,
       from -US$199,306 in the corresponding period ended May 31, 2008, a
       year-over-year increase of more than 400 percent.  However, the
       Company's overall net loss increased to US$2,140,237 for the 12 months
       ended May 31, 2009, of which one of the main expenses affecting the
       results of operations was the stock-based compensation charge of
       US$2,917,125, reflecting the vesting of stock options granted by the
       Company and professional fee of public company administration (audit,
       legal, etc.) of US$270,518.

    -- Increase in sales volume and the improvement in gross profit percentage
       are both due to growth in sales of Cisatracurium Besylate, a pre-
       surgical skeletal muscle relaxant.  Sales of this product increased to
       US$3,595,031 in the 12 months ended May 31, 2009, from US$1,364,165 in
       the 12 months ended May 31, 2008.  At the same time, as volume has
       increased, cost of manufacturing Cisatra
'/>"/>
SOURCE  Sinobiopharma, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 

Related biology technology :

1. Emissary Capital Group Initiates Coverage on Sinobiopharma
2. Sinobiopharma Applies For Two Chinese Patents For Cisatracurium Besylate
3. Sinobiopharma Updates on Progress; Projects Increases in Sales and Revenues In 2009
4. Sinobiopharma Announces SFDA Approval of Anti-Hypertension Drug Perindopril
5. Sinobiopharma Secures Rights to Seven Key Patents
6. Sinobiopharma Reports a 141% Increase in Revenues From Unaudited Financial Results for the 9 Month Period Ended February 28, 2009
7. Sinobiopharma Reports a 41% Increase in Revenues From Unaudited Financial Results for the 9 Month Period Ended February 28, 2009
8. Sinobiopharma, Inc. Appoints New Director of Marketing
9. Sinobiopharma Signs Export Agreement With U.S. Pharmaceutical Supplier
10. Sinobiopharma Reports Financial Highlights for Six-Month Period Ending November 30, 2008
11. Economic Strength of Hawaii Seed Crop Industry Confirmed by Recent Reports
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... Dec. 24, 2014  United Therapeutics Corporation (NASDAQ: ... MDT ) has submitted a pre-market approval application ... the use of Medtronic,s SynchroMed ® II implantable ... use with United Therapeutics, Remodulin ® (treprostinil) Injection ...
(Date:12/24/2014)... 2014  Vermillion, Inc. (Nasdaq:   VRML), a bio-analytical ... that the Company closed its previously announced private ... Jack W. Schuler , Birchview Fund LLC and ... before offering expenses.  The proceeds will be used ...
(Date:12/24/2014)... December 23, 2014 “Preparative & ... HPLC, Flash), Consumables (Columns, Solvents, Buffers, Valves, Guages, ... & Agriculture) - Forecasts to 2019” provides a ... opportunities, current market trends, and strategies impacting the ...
(Date:12/24/2014)... Boston, MA (PRWEB) December 23, 2014 Earlier ... James L. Sherley, director of the Adult Stem Cell Technology ... overlooked and under appreciated unique property of adult tissue stem ... Misunderstood in the Past, Important for the Future,” embodied the ...
Breaking Biology Technology:United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 2United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 3United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 4Vermillion Announces Closing of Equity Financing 2Vermillion Announces Closing of Equity Financing 3Preparative and Process Chromatography Market is expected to reach $9 billion by 2019 - New Report by Marketsandmarkets 2Preparative and Process Chromatography Market is expected to reach $9 billion by 2019 - New Report by Marketsandmarkets 3Preparative and Process Chromatography Market is expected to reach $9 billion by 2019 - New Report by Marketsandmarkets 4Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 2Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 3Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 4
... 2011  Synergy Pharmaceuticals, Inc. (Nasdaq: SGYPD, SGYPU), a developer of ... today that it has filed a lawsuit in New York ... IRWD ) and its Chief Scientific Officer and Senior VP ... lawsuit alleges that after European patent 1,379,224 was granted to ...
... (Nasdaq: SGMO ) announced the presentation of new ... in an adult mouse model of hemophilia B using systemic ... Meeting of the American Society of Hematology (ASH). ... the clotting factor, Factor IX, with a single, systemic administration ...
... The Pharmabiotic Research Institute (PRI) brings together industrial and ... is a unique scientific and regulatory association in Europe. ... traditional food processing applications, probiotics can also be active ... why PRI uses the terminology "Pharmabiotics", relating to "LBP ...
Cached Biology Technology:Synergy Pharmaceuticals, Inc. Files Suit Against Ironwood Pharmaceuticals, Inc. and its Chief Scientific Officer and Senior VP of R&D, Dr. Mark G. Currie 2Sangamo BioSciences Announces Presentation of New Data from ZFP Therapeutic® Program in Hemophilia B at American Society for Hematology Meeting 2Sangamo BioSciences Announces Presentation of New Data from ZFP Therapeutic® Program in Hemophilia B at American Society for Hematology Meeting 3Sangamo BioSciences Announces Presentation of New Data from ZFP Therapeutic® Program in Hemophilia B at American Society for Hematology Meeting 4The Pharmabiotic Research Institute (PRI) is Preparing to Publish its First Works on the Therapeutic and Medicinal Potential of Probiotics 2The Pharmabiotic Research Institute (PRI) is Preparing to Publish its First Works on the Therapeutic and Medicinal Potential of Probiotics 3The Pharmabiotic Research Institute (PRI) is Preparing to Publish its First Works on the Therapeutic and Medicinal Potential of Probiotics 4
(Date:1/22/2015)... 15, 2015  BellBrook Labs, a leader in high ... launch of a TR-FRET (time resolved Forster resonance ... Assay, a high throughput screening assay for glycosyltransferases ... allow for sensitive detection of hundreds of human ...
(Date:1/22/2015)... , Jan. 20, 2015 NXT-ID, Inc. (NASDAQ: NXTD ... market, reports on the recent success of the Wocket™ smart wallet at ... Wocket smart wallet was named as one of the "11 Hot Products ... Best Products Launched At CES So Far" by Newseveryday.com and "The top ...
(Date:1/22/2015)... Issued by Small Cap IR. In 2011, Nilson Report,s annual ... merchants on the leading payment cards rose to $135.3 billion ... prepaid cards reached 6.54 billion.  Eight million credit card users ... 2012, and credit and debit card fraud resulted in $11.27 ...
Breaking Biology News(10 mins):BellBrook Labs Launches a High Throughput Screening Assay for Glycosyltransferases with TR-FRET Readout 2CES Response for NXT-ID's Wocket Smart Wallet Kicks Off 2015 2CES Response for NXT-ID's Wocket Smart Wallet Kicks Off 2015 3$4.80 Near Term Price Target with "Buy" given by CapRock Research for NXT-ID, Inc. (NASDAQ: NXTD) issued by Small Cap IR 2
... Finding cures for hearing loss, breast cancer and childhood ... for tuberculosis are goals of the first recipients of ... Collaborative Research Fund. The fund, a $3 million initiative ... supports collaboration among researchers at Rice University, Texas Children,s ...
... three undergraduates set off on an expedition in 1965 to ... realise that they were establishing the groundwork for a study ... led by the University of York has repeated the survey ... moved uphill by about 67 metres over the intervening years ...
... COLUMBIA, Mo. When it is head versus heart, ... organ to develop and is critical in supplying blood ... known about the complex processes that regulate the heartbeat. ... has identified certain proteins within the heart muscle that ...
Cached Biology News:Texas Medical Center researchers win collaborative grants 2Texas Medical Center researchers win collaborative grants 3Texas Medical Center researchers win collaborative grants 4The global impact of climate change on biodiversity 2Researchers examine developing hearts in chickens to find solutions for human heart abnormalities 2
Human Norrin Biotinylated Affinity Purified PAb Protein Family: Other Growth Factors, Other Wnt-related Molecules...
...
Recombinant Mouse Matrilin-4, CF Protein Family: Extracellular Matrix Molecules, Chondrogenesis Markers...
Request Info...
Biology Products: